Equities

Orchid Pharma Ltd

ORCHPHARMA:NSI

Orchid Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,392.80
  • Today's Change21.90 / 1.60%
  • Shares traded114.51k
  • 1 Year change+167.15%
  • Beta3.4160
Data delayed at least 15 minutes, as of Sep 20 2024 11:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income890463(20)
Depreciation/depletion332548870
Non-Cash items107(34)(503)
Cash taxes paid, supplemental(6.29)2.9919
Cash interest paid, supplemental164322320
Changes in working capital(72)(794)577
Total cash from operations1,258183925
INVESTING
Capital expenditures(648)(849)(144)
Other investing and cash flow items, total(2472)5371,273
Total cash from investing(3120)(312)1,129
FINANCING
Financing cash flow items(164)(322)(320)
Total cash dividends paid------
Issuance (retirement) of stock, net3,919----
Issuance (retirement) of debt, net(2085)634(1848)
Total cash from financing1,670312(2168)
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(190)183(114)
Net cash-begin balance/reserved for future use22643157
Net cash-end balance/reserved for future use3622643
SUPPLEMENTAL INCOME
Depreciation, supplemental332548870
Cash interest paid, supplemental164322320
Cash taxes paid, supplemental(6.29)2.9919
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.